ACLARIS THERAPEUTICS INC (ACRS) — institutional ownership
157 funds reported holding ACLARIS THERAPEUTICS INC in their latest 13F filings, worth $659M in total (CUSIP 00461U105).
Largest holders
- RA CAPITAL MANAGEMENT, L.P. — $67.3M
- BML Capital Management, LLC — $63.3M
- BlackRock, Inc. (BLK) — $53.1M
- Deep Track Capital, LP — $49.4M
- Vivo Capital, LLC — $35.4M
- VANGUARD CAPITAL MANAGEMENT LLC — $30.8M
- Frazier Life Sciences Management, L.P. — $26.1M
- Rock Springs Capital Management LP — $22.9M
- ADAGE CAPITAL PARTNERS GP, L.L.C. — $21.5M
- Decheng Capital LLC — $21.4M
Famous investors holding it
- Ken Griffin portfolio (Citadel Advisors)
- Renaissance Technologies portfolio (Renaissance Technologies)
- Izzy Englander portfolio (Millennium Management)
- D. E. Shaw portfolio (D. E. Shaw & Co.)
- Two Sigma portfolio (Two Sigma Investments)
Insider buying and selling at ACLARIS THERAPEUTICS INC
Who owns the most ACRS stock?
The largest institutional holders in the latest 13F filings are RA CAPITAL MANAGEMENT, L.P. ($67.3M), BML Capital Management, LLC ($63.3M), BlackRock, Inc. (BLK) ($53.1M).
How many funds own ACRS?
157 funds reported holding it, worth $659M in total.